Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mehdi Touat, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Picca A, Desjardins C, Bihan K, Weiss N, Guihot A, Nichelli L, Feuvret L, Pourcher V, Touat M, Dehais C. Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma. Neuro Oncol. 2022 03 12; 24(3):497-498. PMID: 35038339.
    Citations:    Fields:    
  2. Baldini C, Younan N, Castanon Alvarez E, Ammari S, Alentorn A, Dumont S, Frenel JS, Di Stefano AL, Louvel G, Michot JM, Bahleda R, Postel-Vinay S, Varga A, Marabelle A, Hollebecque A, Bielle F, Hoang-Xuan K, Delattre JY, Dhermain F, Sanson M, Soria JC, Idbaih A, Massard C, Touat M. Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. Eur J Cancer. 2022 Mar; 163:98-107. PMID: 35063776.
    Citations:    Fields:    
  3. Mathon B, Favreau M, Degos V, Amelot A, Le Joncour A, Weiss N, Rohaut B, Le Guennec L, Boch AL, Carpentier A, Bielle F, Mokhtari K, Idbaih A, Touat M, Combes A, Demoule A, Shotar E, Navarro V, Raux M, Demeret S, Pineton De Chambrun M. Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Crit Care Med. 2022 Jan 10. PMID: 34995211.
    Citations:    Fields:    
  4. Lim-Fat MJ, Youssef GC, Touat M, Iorgulescu JB, Whorral S, Allen M, Rahman R, Chukwueke U, McFaline-Figueroa JR, Nayak L, Lee EQ, Batchelor TT, Arnaout O, Peruzzi PP, Chiocca EA, Reardon DA, Meredith D, Santagata S, Beroukhim R, Bi WL, Ligon KL, Wen PY. Clinical utility of targeted next generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making. Neuro Oncol. 2021 Dec 08. PMID: 34878541.
    Citations:    Fields:    
  5. Fontanilles M, Sanson M, Touat M. Liquid biopsy in neuro-oncology: are we finally there? Ann Oncol. 2021 12; 32(12):1472-1474. PMID: 34815016.
    Citations:    Fields:    Translation:Humans
  6. Ammari S, Sallé de Chou R, Balleyguier C, Chouzenoux E, Touat M, Quillent A, Dumont S, Bockel S, Garcia GCTE, Elhaik M, Francois B, Borget V, Lassau N, Khettab M, Assi T. A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI. Diagnostics (Basel). 2021 Nov 04; 11(11). PMID: 34829395.
  7. Prost D, Bielle F, Ligon KL, Touat M. Mutational burden and immune recognition of gliomas. Curr Opin Oncol. 2021 11 01; 33(6):626-634. PMID: 34651608.
    Citations: 1     Fields:    Translation:Humans
  8. Stockslager MA, Malinowski S, Touat M, Yoon JC, Geduldig J, Mirza M, Kim AS, Wen PY, Chow KH, Ligon KL, Manalis SR. Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models. Cell Rep. 2021 10 05; 37(1):109788. PMID: 34610309.
    Citations: 2     Fields:    Translation:HumansCells
  9. Riche M, Marijon P, Amelot A, Bielle F, Mokhtari K, Chambrun MP, Joncour AL, Idbaih A, Touat M, Do CH, Deme M, Pasqualotto R, Jacquens A, Degos V, Shotar E, Chougar L, Carpentier A, Mathon B. Severity, timeline, and management of complications after stereotactic brain biopsy. J Neurosurg. 2022 Mar 01; 136(3):867-876. PMID: 34507289.
    Citations: 2     Fields:    
  10. Spurr LF, Touat M, Taylor AM, Dubuc AM, Shih J, Meredith DM, Pisano WV, Meyerson ML, Ligon KL, Cherniack AD, Li YY, Beroukhim R. Quantification of aneuploidy in targeted sequencing data using ASCETS. Bioinformatics. 2021 08 25; 37(16):2461-2463. PMID: 33247715.
    Citations: 2     Fields:    Translation:Humans
  11. Bouzidi A, Labreche K, Baron M, Veyri M, Denis JA, Touat M, Sanson M, Davi F, Guillerm E, Jouannet S, Charlotte F, Bielle F, Choquet S, Boëlle PY, Cadranel J, Leblond V, Autran B, Lacorte JM, Spano JP, Coulet F. Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations. Front Cell Dev Biol. 2021; 9:661272. PMID: 34710202.
  12. Ammari S, Sallé de Chou R, Assi T, Touat M, Chouzenoux E, Quillent A, Limkin E, Dercle L, Hadchiti J, Elhaik M, Moalla S, Khettab M, Balleyguier C, Lassau N, Dumont S, Smolenschi C. Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab. Diagnostics (Basel). 2021 Jul 14; 11(7). PMID: 34359346.
    Citations: 1     
  13. Opatowski M, Brun-Buisson C, Touat M, Salomon J, Guillemot D, Tuppin P, Watier L. Correction to: Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS). BMC Infect Dis. 2021 Jun 29; 21(1):615. PMID: 34187379.
    Citations:    Fields:    
  14. Lozano-Sanchez F, Ursu R, Di-Stefano AL, Ducray F, Younan N, Touat M, Groh M, Agguini H, Belin C, Garnier L, Delattre JY, Carpentier A, Idbaih A. Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab078. PMID: 34396128.
  15. Opatowski M, Brun-Buisson C, Touat M, Salomon J, Guillemot D, Tuppin P, Watier L. Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS). BMC Infect Dis. 2021 Jun 14; 21(1):571. PMID: 34126937.
    Citations: 1     Fields:    Translation:Humans
  16. Berzero G, Bellu L, Baldini C, Ducray F, Guyon D, Eoli M, Silvani A, Dehais C, Idbaih A, Younan N, Nguyen-Them L, Gaillard S, Pasqualetti F, Lepage-Seydoux C, Sekkate S, Tresca P, Kas A, Gratieux J, Ammari S, Saragoussi E, Savatovsky J, Delattre JY, Hoang-Xuan K, Meyronet D, Villa C, Bielle F, Sanson M, Touat M, Di Stefano AL. Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors. Neurology. 2021 08 17; 97(7):e673-e683. PMID: 34088874.
    Citations: 1     Fields:    Translation:Humans
  17. Ratovomanana T, Cohen R, Svrcek M, Renaud F, Cervera P, Siret A, Letourneur Q, Buhard O, Bourgoin P, Guillerm E, Dorard C, Nicolle R, Ayadi M, Touat M, Bielle F, Sanson M, Le Rouzic P, Buisine MP, Piessen G, Collura A, Fléjou JF, de Reyniès A, Coulet F, Ghiringhelli F, André T, Jonchère V, Duval A. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. Gastroenterology. 2021 09; 161(3):814-826.e7. PMID: 33992635.
    Citations: 3     Fields:    Translation:HumansCells
  18. Touat M, Brun-Buisson C, Opatowski M, Salomon J, Guillemot D, Tuppin P, de Lagasnerie G, Watier L. Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria. J Infect. 2021 03; 82(3):339-345. PMID: 33556428.
    Citations: 1     Fields:    Translation:HumansCells
  19. Dufour J, Mathon B, Touat M, Hoang-Xuan K, Mokhtari K, Idbaih A. BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system. Rev Neurol (Paris). 2021 06; 177(6):708-710. PMID: 33478735.
    Citations:    Fields:    Translation:Humans
  20. Laurenge A, Ursu R, Houillier C, Abdi B, Tebano G, Quemeneur C, Choquet S, Di Blasi R, Lozano F, Morales A, Durán-Peña A, Sirven-Villaros L, Mathon B, Mokhtari K, Bielle F, Martin-Duverneuil N, Delattre JY, Marcelin AG, Pourcher V, Alentorn A, Idbaih A, Carpentier AF, Leblond V, Hoang-Xuan K, Touat M. SARS-CoV-2 infection in patients with primary central nervous system lymphoma. J Neurol. 2021 Sep; 268(9):3072-3080. PMID: 33387015.
    Citations: 2     Fields:    Translation:HumansCells
  21. Rudà R, Touat M, Soffietti R. Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas? Curr Opin Neurol. 2020 12; 33(6):707-715. PMID: 33027142.
    Citations:    Fields:    Translation:Humans
  22. Chabaane M, Amelot A, Riche M, Bielle F, Mokhtari K, Carpentier A, Touat M, Mathon B. Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity. J Clin Neurol. 2020 Oct; 16(4):659-667. PMID: 33029973.
  23. Dufour J, Mathon B, Touat M, Hoang-Xuan K, Karima M, Idbaih A. Rev Neurol (Paris). 2020 Sep; 176S:S48. PMID: 32906438.
    Citations:    Fields:    
  24. Musat EM, Berzero G, Bielle F, Laurent C, Sanson M, Touat M. Rev Neurol (Paris). 2020 Sep; 176S:S49. PMID: 32906441.
    Citations:    Fields:    
  25. Valyraki N, Houillier C, Touat M, Hoang-Xuan K. Rev Neurol (Paris). 2020 Sep; 176S:S46-S47. PMID: 32906433.
    Citations:    Fields:    
  26. Birzu C, Tran S, Bielle F, Touat M, Mokhtari K, Younan N, Psimaras D, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges. Oncologist. 2020 11; 25(11):e1763-e1776. PMID: 33394574.
    Citations: 7     Fields:    Translation:Humans
  27. Federici L, Capelle L, Annereau M, Bielle F, Willekens C, Dehais C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Idbaih A, Lemare F, de Botton S, Sanson M, Touat M. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma. Neuro Oncol. 2020 08 17; 22(8):1226-1228. PMID: 32215616.
    Citations: 6     Fields:    Translation:Humans
  28. Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, Lu M, Bowden C, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma. J Clin Oncol. 2020 10 10; 38(29):3398-3406. PMID: 32530764.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  29. Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, Bellamy C, Currimjee N, Bonardi J, Qian K, Ho P, Malinowski S, Taquet L, Jones RE, Shetty A, Chow KH, Sharaf R, Pavlick D, Albacker LA, Younan N, Baldini C, Verreault M, Giry M, Guillerm E, Ammari S, Beuvon F, Mokhtari K, Alentorn A, Dehais C, Houillier C, Laigle-Donadey F, Psimaras D, Lee EQ, Nayak L, McFaline-Figueroa JR, Carpentier A, Cornu P, Capelle L, Mathon B, Barnholtz-Sloan JS, Chakravarti A, Bi WL, Chiocca EA, Fehnel KP, Alexandrescu S, Chi SN, Haas-Kogan D, Batchelor TT, Frampton GM, Alexander BM, Huang RY, Ligon AH, Coulet F, Delattre JY, Hoang-Xuan K, Meredith DM, Santagata S, Duval A, Sanson M, Cherniack AD, Wen PY, Reardon DA, Marabelle A, Park PJ, Idbaih A, Beroukhim R, Bandopadhayay P, Bielle F, Ligon KL. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 2020 04; 580(7804):517-523. PMID: 32322066.
    Citations: 107     Fields:    Translation:HumansAnimalsCells
  30. Touat M, Younan N, Euskirchen P, Fontanilles M, Mokhtari K, Dehais C, Tilleul P, Rahimian-Aghda A, Resnick A, Gimenez-Roqueplo AP, Blons H, Hoang-Xuan K, Delattre JY, Idbaih A, Laurent-Puig P, Sanson M. Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination. JCO Precis Oncol. 2019 Dec; 3:1-7. PMID: 35100676.
    Citations:    Fields:    
  31. Boisseau W, Euskirchen P, Mokhtari K, Dehais C, Touat M, Hoang-Xuan K, Sanson M, Capelle L, Nouet A, Karachi C, Bielle F, Guégan J, Marie Y, Martin-Duverneuil N, Taillandier L, Rousseau A, Delattre JY, Idbaih A. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. Oncologist. 2019 12; 24(12):1584-1592. PMID: 31346129.
    Citations: 7     Fields:    Translation:Humans
  32. Touat M, Opatowski M, Brun-Buisson C, Cosker K, Guillemot D, Salomon J, Tuppin P, de Lagasnerie G, Watier L. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study. Appl Health Econ Health Policy. 2019 06; 17(3):381-389. PMID: 30506456.
    Citations: 8     Fields:    Translation:Humans
  33. Knauss S, Preusse C, Allenbach Y, Leonard-Louis S, Touat M, Fischer N, Radbruch H, Mothes R, Matyash V, Böhmerle W, Endres M, Goebel HH, Benveniste O, Stenzel W. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e558. PMID: 31044146.
    Citations: 8     Fields:    Translation:HumansCells
  34. Wen PY, Touat M, Alexander BM, Mellinghoff IK, Ramkissoon S, McCluskey CS, Pelton K, Haidar S, Basu SS, Gaffey SC, Brown LE, Martinez-Ledesma JE, Wu S, Kim J, Wei W, Park MA, Huse JT, Kuhn JG, Rinne ML, Colman H, Agar NYR, Omuro AM, DeAngelis LM, Gilbert MR, de Groot JF, Cloughesy TF, Chi AS, Roberts TM, Zhao JJ, Lee EQ, Nayak L, Heath JR, Horky LL, Batchelor TT, Beroukhim R, Chang SM, Ligon AH, Dunn IF, Koul D, Young GS, Prados MD, Reardon DA, Yung WKA, Ligon KL. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750. PMID: 30715997.
    Citations: 37     Fields:    Translation:HumansCellsCTClinical Trials
  35. Opatowski M, Tuppin P, Cosker K, Touat M, De Lagasnerie G, Guillemot D, Salomon J, Brun-Buisson C, Watier L. Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016. Epidemiol Infect. 2019 01; 147:e144. PMID: 30869047.
    Citations: 2     Fields:    Translation:HumansCells
  36. Dunn IF, Du Z, Touat M, Sisti MB, Wen PY, Umeton R, Dubuc AM, Ducar M, Canoll PD, Severson E, Elvin JA, Ramkissoon SH, Lin JR, Cabrera L, Acevedo B, Sorger PK, Ligon KL, Santagata S, Reardon DA. Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. JCO Precis Oncol. 2018; 2018. PMID: 30801050.
    Citations: 16     Fields:    
  37. Calistri NL, Kimmerling RJ, Malinowski SW, Touat M, Stevens MM, Olcum S, Ligon KL, Manalis SR. Microfluidic active loading of single cells enables analysis of complex clinical specimens. Nat Commun. 2018 11 14; 9(1):4784. PMID: 30429479.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  38. Kaley T, Touat M, Subbiah V, Hollebecque A, Rodon J, Lockhart AC, Keedy V, Bielle F, Hofheinz RD, Joly F, Blay JY, Chau I, Puzanov I, Raje NS, Wolf J, DeAngelis LM, Makrutzki M, Riehl T, Pitcher B, Baselga J, Hyman DM. BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study. J Clin Oncol. 2018 12 10; 36(35):3477-3484. PMID: 30351999.
    Citations: 78     Fields:    Translation:HumansCTClinical Trials
  39. Appay R, Tabouret E, Touat M, Carpentier C, Colin C, Ducray F, Idbaih A, Mokhtari K, Uro-Coste E, Dehais C, Figarella-Branger D. Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome. Acta Neuropathol Commun. 2018 09 07; 6(1):89. PMID: 30193580.
    Citations: 5     Fields:    Translation:Humans
  40. Touat M, Gratieux J, Condette Auliac S, Sejean K, Aldea S, Savatovsky J, Perkins G, Blons H, Ligon KL, Idbaih A, Hollebecque A, Gimenez-Roqueplo AP, Laurent-Puig P, Sanson M, Villa C, Di Stefano AL. Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma. Neurology. 2018 09 11; 91(11):523-525. PMID: 30120137.
    Citations: 7     Fields:    Translation:Humans
  41. Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, Béhin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, Léonard-Louis S. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology. 2018 09 04; 91(10):e985-e994. PMID: 30089619.
    Citations: 75     Fields:    Translation:Humans
  42. Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J. Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma. J Neurooncol. 2018 Nov; 140(2):317-328. PMID: 30073642.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  43. Touat M, Michaud M, Alamowitch S, Maisonobe T, Acquaviva-Bourdain C, Laforêt P. Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Rev Neurol (Paris). 2018 Dec; 174(10):747-750. PMID: 30072122.
    Citations:    Fields:    Translation:Humans
  44. Picca A, Berzero G, Bielle F, Touat M, Savatovsky J, Polivka M, Trisolini E, Meunier S, Schmitt Y, Idbaih A, Hoang-Xuan K, Delattre JY, Mokhtari K, Di Stefano AL, Sanson M. FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. Neurology. 2018 06 05; 90(23):e2086-e2094. PMID: 29728520.
    Citations: 15     Fields:    Translation:HumansCells
  45. Appay R, Tabouret E, Macagno N, Touat M, Carpentier C, Colin C, Ducray F, Idbaih A, Mokhtari K, Uro-Coste E, Dehais C, Figarella-Branger D. IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. Neuro Oncol. 2018 04 09; 20(5):716-718. PMID: 29522183.
    Citations: 6     Fields:    Translation:HumansCells
  46. Touat M, Sourisseau T, Dorvault N, Chabanon RM, Garrido M, Morel D, Krastev DB, Bigot L, Adam J, Frankum JR, Durand S, Pontoizeau C, Souquère S, Kuo MS, Sauvaigo S, Mardakheh F, Sarasin A, Olaussen KA, Friboulet L, Bouillaud F, Pierron G, Ashworth A, Lombès A, Lord CJ, Soria JC, Postel-Vinay S. DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade. J Clin Invest. 2018 04 02; 128(4):1671-1687. PMID: 29447131.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  47. Delahousse J, Verlingue L, Broutin S, Legoupil C, Touat M, Doucet L, Ammari S, Lacroix L, Ducreux M, Scoazec JY, Malka D, Paci A, Hollebecque A. Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas. Eur J Cancer. 2018 02; 90:83-91. PMID: 29274619.
    Citations: 9     Fields:    Translation:HumansCells
  48. Touat M, Talmasov D, Ricard D, Psimaras D. Neurological toxicities associated with immune-checkpoint inhibitors. Curr Opin Neurol. 2017 Dec; 30(6):659-668. PMID: 28938341.
    Citations: 45     Fields:    Translation:Humans
  49. Bahleda R, Le Deley MC, Bernard A, Chaturvedi S, Hanley M, Poterie A, Gazzah A, Varga A, Touat M, Deutsch E, Massard C, Van De Velde H, Hollebecque A, Sallansonnet-Froment M, Ricard D, Taillia H, Angevin E, Ribrag V, Soria JC. Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors. Invest New Drugs. 2018 08; 36(4):619-628. PMID: 29094232.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  50. Boisseau W, Touat M, Berzero G, Savatovsky J, Marabelle A, Touitou V, Ricard D, Malouf G, Psimaras D. Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy. Eur J Cancer. 2017 09; 83:28-31. PMID: 28710954.
    Citations: 7     Fields:    Translation:Humans
  51. Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol. 2017 Jul 01; 28(7):1457-1472. PMID: 28863449.
    Citations: 145     Fields:    Translation:HumansAnimalsCells
  52. Carle G, Touat M, Bruno N, Galanaud D, Peretti CS, Valero-Cabré A, Levy R, Azuar C. Acute Frontal Lobe Dysfunction Following Prefrontal Low-Frequency Repetitive Transcranial Magnetic Stimulation in a Patient with Treatment-Resistant Depression. Front Psychiatry. 2017; 8:96. PMID: 28611694.
    Citations: 1     
  53. Mondesir J, Willekens C, Touat M, de Botton S. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med. 2016; 7:171-80. PMID: 27621679.
    Citations: 76     
  54. Touat M, Idbaih A, Sanson M. Radiation plus Chemotherapy in Low-Grade Glioma. N Engl J Med. 2016 08 04; 375(5):489-90. PMID: 27518678.
    Citations:    Fields:    Translation:Humans
  55. Vallet H, Gaillet A, Weiss N, Vanhaecke C, Saheb S, Touitou V, Franck N, Kramkimel N, Borden A, Touat M, Ricard D, Verny M, Maisonobe T, Psimaras D. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma. Ann Oncol. 2016 07; 27(7):1352-3. PMID: 26940685.
    Citations: 22     Fields:    Translation:Humans
  56. Touat M, Ileana E, Postel-Vinay S, André F, Soria JC. Targeting FGFR Signaling in Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2684-94. PMID: 26078430.
    Citations: 171     Fields:    Translation:HumansCells
  57. dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G. Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. J Neurooncol. 2015 Jun; 123(2):307-14. PMID: 25975195.
    Citations: 8     Fields:    Translation:Humans
  58. Touat M, Dhermain F, André F, Sanson M. Adapting the drivers to the road: a new strategy for cancer evolution? Ann Oncol. 2015 May; 26(5):827-829. PMID: 25748650.
    Citations: 2     Fields:    Translation:Humans
  59. Di Stefano AL, Fucci A, Frattini V, Labussiere M, Mokhtari K, Zoppoli P, Marie Y, Bruno A, Boisselier B, Giry M, Savatovsky J, Touat M, Belaid H, Kamoun A, Idbaih A, Houillier C, Luo FR, Soria JC, Tabernero J, Eoli M, Paterra R, Yip S, Petrecca K, Chan JA, Finocchiaro G, Lasorella A, Sanson M, Iavarone A. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma. Clin Cancer Res. 2015 Jul 15; 21(14):3307-17. PMID: 25609060.
    Citations: 111     Fields:    Translation:HumansAnimalsCTClinical Trials
  60. DiFrancesco JC, Touat M, Caulo M, Gallucci M, Garcin B, Levy R, Uncini A, Piazza F. Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAß International Network. J Alzheimers Dis. 2015; 46(4):1071-7. PMID: 26402633.
    Citations: 6     Fields:    Translation:Humans
  61. Touat M, Duran-Peña A, Alentorn A, Lacroix L, Massard C, Idbaih A. Emerging circulating biomarkers in glioblastoma: promises and challenges. Expert Rev Mol Diagn. 2015; 15(10):1311-23. PMID: 26394701.
    Citations: 28     Fields:    Translation:HumansCells
  62. Touat M, Lombardi G, Farina P, Kalamarides M, Sanson M. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486). Acta Neurochir (Wien). 2014 Oct; 156(10):1831-5. PMID: 25078073.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Touat's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (231)
Co-Authors (44)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.